Apple Inc. vs. LYRA THERAPEUTICS INC
Apple Inc. (AAPL) comes out ahead, leading on 3 of 4 compared factors.
Size & Scale
| AAPL | LYRA | |
|---|---|---|
| Market Cap | $4.91 trillion | — |
| Revenue (TTM) | $466.82 billion | $398,000 |
| Net Income (TTM) | $128.93 billion | $-28,919,000 |
AAPL leads on 2 of 2 size & scale factors.
Valuation
| AAPL | LYRA | |
|---|---|---|
| P/E Ratio | 38.55 | — |
| Price / Book | 45.62 | — |
| Price / Sales | 10.51 | — |
AAPL and LYRA split the valuation factors evenly.
Profitability
| AAPL | LYRA | |
|---|---|---|
| Net Margin | 27.62% | -7266.08% |
| Return on Equity | 119.91% | 269.84% |
AAPL and LYRA split the profitability factors evenly.
Dividend
| AAPL | LYRA | |
|---|---|---|
| Dividend Yield | 0.32% | — |
| Payout Ratio | 12.39 | — |
AAPL and LYRA split the dividend factors evenly.
Risk & Sentiment
| AAPL | LYRA | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and LYRA split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, LYRA overview, LYRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.